[Ischaemic heart disease]

Carlos Brotons1, José I Cuende2, Jacinto Fernández Pardo3

  • 1Unidad de Investigación, Equip d'Atenció Primària Sardenya, Unidad Docente ACEBA, Instituto de Investigación Biomédica Sant Pau (IIB-Sant Pau), Barcelona, España.

Insights

Cardiovascular diseases caused 31.2% of Spanish deaths in 2011, but hospitalization rates decreased by 24.4% between 2003 and 2011. Despite reduced mortality, risk factors like obesity and uncontrolled blood pressure remain prevalent in patients with ischaemic heart disease.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Context:

  • Cardiovascular diseases (CVDs) represent a significant public health burden in Spain.
  • In 2011, CVDs accounted for 31.2% of all deaths and were the leading cause of hospitalization (14.1%).
  • Specific conditions like acute coronary syndrome and ischaemic heart disease contribute substantially to morbidity and healthcare utilization.

Purpose:

  • To analyze the epidemiological trends and healthcare costs associated with cardiovascular diseases in Spain.
  • To assess the prevalence of cardiovascular risk factors and medication use in patients with ischaemic heart disease.
  • To evaluate changes in hospitalization rates and mortality over time.

Summary:

  • In 2011, cardiovascular diseases caused approximately 115,752 cases of acute coronary syndrome and led to 14.1% of total hospitalizations in Spain.
  • Hospitalization rates for ischaemic heart disease decreased by 24.4% from 2003 to 2011, and mortality rates showed a relative reduction of 7-8% in women and men respectively between 2007-2011.
  • Despite these improvements, a European survey (EUROASPIREIII) indicated high prevalence of uncontrolled risk factors (hypertension, high cholesterol, diabetes, obesity) and ongoing smoking among ischaemic heart disease patients.

Impact:

  • The findings highlight a positive trend in reducing cardiovascular mortality and hospitalizations, yet underscore the persistent challenge of managing risk factors.
  • Understanding these trends is crucial for public health policy and resource allocation in cardiovascular disease prevention and management.
  • The study provides valuable data on the economic impact, with average hospitalization costs for ischaemic heart disease increasing significantly from 1997 to 2011.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
814